To systematically elaborate on the latest advances in the clinical application of dual-energy CT (DECT) for gastric tumor evaluation and other gastric diseases.
Key Findings:
DECT improves early detection rates of gastric tumors.
DECT aids in differentiating between benign and malignant lesions.
DECT allows for precise preoperative staging.
DECT facilitates therapeutic response assessment.
Interpretation:
DECT provides rich, multidimensional quantitative metrics for comprehensive evaluation of gastric tumors, enhancing diagnostic performance and precision.
Limitations:
Conclusion:
With hardware upgrades and integration with AI technologies, DECT is expected to play a more central role in precision medicine and longitudinal management of gastric cancer.
